On February 20, 2026, in Padova, Italy, the biennial Penta Brighter Future Award recognized seven public‑health leaders tackling inequities in maternal and child infectious diseases—spanning HIV, tuberculosis (TB), vaccine access, and the resilience of fragile health systems. The program, run by the Penta Foundation, uses a peer‑nomination process and a two‑tiered international jury to elevate locally grounded solutions with global relevance. Full program details are available on the Penta Brighter Future Award page.
Awardees and focus areas
Together, the 2026 laureates span six regions and a continuum of care from prevention and diagnosis to long‑term treatment access. Their work echoes priorities embedded in global commitments such as the Sustainable Development Goal 3 framework on maternal and child health, but is rooted in the operational realities of front‑line systems.
| Awardee | Country/Region | Primary focus | System lever highlighted | Population focus |
|---|---|---|---|---|
| Namakau Mundia | Zambia | HIV and sexual/reproductive health | Adolescent‑friendly services; integration of SRH and HIV platforms | Adolescent girls and young women |
| Ayat Al‑Saqqa | Palestine | Reproductive health services and laboratory diagnostics | Restoration of essential services and labs during humanitarian crises | Pregnant women and newborns in crisis settings |
| Cecilia Bernardoni | Venezuela | Continuity of antiretroviral therapy | Supply‑chain reliability; treatment retention for children with HIV | Children living with HIV |
| África Holguín | Spain (multi‑region) | Paediatric HIV detection and treatment | Regional lab networks; early infant diagnosis and linkage to care | Infants and children across Europe, Latin America, and Africa |
| Vincent Guilamo‑Ramos | United States | Family‑based HIV prevention | Community‑embedded prevention models; culturally responsive care | U.S. Latino communities |
| Pauline Masta | Papua New Guinea | Maternal TB screening | Integration of TB screening into frontline maternity services | Pregnant women and newborns |
| Helen Skirrow | United Kingdom | Equitable maternal and childhood vaccination | Data‑driven outreach; reducing geographic and social coverage gaps | Underserved families and communities |
Public‑health significance across HIV, TB and immunization
For health ministers, local authorities, and donors, the awardees’ work illustrates how technical interventions translate into real reductions in avoidable illness and death.
- Health outcomes
- Early infant diagnosis and uninterrupted paediatric HIV treatment reduce mortality, support the global elimination of vertical transmission targets, and prevent onward transmission within households.
- Screening for TB in pregnancy improves detection of active disease, lowering risks of adverse maternal and neonatal outcomes and reinforcing antenatal care as a key TB‑control platform in high‑burden settings.
- Sustained vaccine uptake protects against outbreaks that disproportionately impact infants, pregnant people, and underserved populations, helping countries maintain hard‑won gains in immunization coverage.
- Population impacts
- Adolescent girls and young women face higher structural and social risk for HIV; responsive, rights‑based services can narrow gendered inequities and support broader sexual and reproductive health goals.
- Communities in humanitarian crises experience collapsed diagnostics and disrupted maternity care; rapid restoration of lab and perinatal services stabilizes essential care pathways and reduces long‑term system damage.
- U.S. Latino communities benefit from family‑centered prevention models that address language, trust, and access barriers, complementing national efforts to reduce HIV incidence and reinforce community‑based primary care.
System capacity and governance implications
Beyond individual programs, the 2026 cohort points to structural levers that regulators, health‑system managers, and financing partners can influence.
- Service integration
- Embedding TB screening, HIV testing, and reproductive health within antenatal and primary care reduces missed opportunities for prevention and treatment and encourages ministries to design benefit packages that reflect integrated, life‑course care.
- Laboratory and surveillance
- Networked labs, validated diagnostics, and timely result reporting are core to paediatric HIV case‑finding and maternal TB care, enabling national programs to meet surveillance obligations and respond quickly to gaps.
- Data systems should enable equity monitoring—by geography, age, and socio‑economic status—while safeguarding patient privacy and complying with data‑protection law and professional oversight.
- Supply chains and pharmacovigilance
- Reliable procurement and cold‑chain capacity sustain antiretroviral therapy and immunization schedules, supported by national formularies, quality assurance, and independent pharmacovigilance to detect and act on safety signals.
- Workforce and community partnerships
- Skilled midwives, nurses, and community health workers enable task‑sharing, culturally responsive care, and adherence support, particularly in rural or crisis‑affected settings where physician coverage is limited.
- Accountability
- Transparent purchasing, adverse‑event reporting, and ethics oversight strengthen trust, particularly for services serving minors and crisis‑affected populations, and provide a governance backbone for scale‑up and replication.
Measurement that funders and ministries can track
The awardees’ portfolios translate into concrete indicators that health ministries, municipal authorities, and global funders can embed in performance frameworks and results‑based financing.
| Domain | Example metric (program level) | Institutional locus |
|---|---|---|
| Paediatric HIV | Proportion of infants with early HIV testing completed and linked to treatment | Hospital/lab networks; child health programs |
| ART continuity | Share of children receiving uninterrupted antiretroviral supply within last 3–6 months | Pharmacy and supply‑chain units |
| Maternal TB | Coverage of TB symptom screening and confirmatory testing during antenatal visits | Maternity services; TB programs |
| Immunization equity | Vaccination coverage in the lowest‑coverage districts vs. national average | Immunization programs; sub‑national health departments |
| Humanitarian service restoration | Turnaround time for essential lab diagnostics after service disruption | Emergency operations centers; public labs |
| Community‑centered prevention | Enrollment and retention in family‑based HIV prevention services | Community clinics; public health outreach |
Leadership perspective
“These leaders are not just responding to statistics; they are responding to the real, lived needs of their communities.” — Carlo Giaquinto, President of Penta.
Program organisers say that combination—data‑driven, but grounded in community voice—is what makes the 2026 cohort particularly relevant for policymakers looking to close the gap between national strategies and day‑to‑day experience in clinics.
From announcement to convening
The Padova announcement is designed as a starting point for policy dialogue rather than an end in itself.
- February 20, 2026: Awards announced in Padova, Italy.
- 2026: Laureates to be formally honored at the Penta ID Meeting in Palermo, Italy (biennial scientific congress), where they are expected to share implementation lessons with researchers, national program managers, and multilateral partners.
Why locally grounded solutions are pivotal
For governments under pressure to deliver on national health strategies and international commitments, the award highlights a common thread: reforms only stick when designed with—and not merely for—the communities most affected.
- Risk factors
- Gendered vulnerabilities, poverty, and displacement amplify infectious‑disease risk in pregnancy and childhood, making it harder for countries to reach universal health coverage goals.
- Language, documentation status, and culturally discordant services impede prevention and care in minority communities, even when services are nominally available and free at the point of use.
- Policy measures
- Integrating maternal TB screening into routine antenatal care in high‑burden areas aligns with global guidance and reduces delays in diagnosis, while giving TB programs a clear entry point into reproductive health platforms.
- Using geospatial and deprivation indices to target vaccine outreach helps close sub‑national coverage gaps, supporting national immunization plans and performance‑based budgeting.
- Family‑centered HIV prevention models leverage trusted relationships and improve uptake over siloed, individual‑only approaches, particularly where stigma remains a barrier to clinic‑based care.
- System capacity
- Strengthened lab networks and protected supply chains are foundational for continuity of antiretroviral therapy and accurate diagnosis in crises, enabling governments to maintain essential services during shocks.
- Community health workers and midwives extend reach where physician density is low, improving linkage and follow‑up and offering a practical route to scaling interventions without overburdening tertiary hospitals.
The 2026 cohort underscores a clear theme: durable progress on maternal, newborn, and child health depends on institutions that pair scientific rigor with culturally responsive delivery. By centering adolescents, mothers, children, and communities living through conflict or marginalization, these initiatives convert equity commitments into measurable system change—and offer concrete models that national authorities and global health partners can adapt, fund, and regulate for the next phase of maternal and child health policy.